BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cytiva Introduces Supor Prime Filters to Enhance High-Concentration Biologic Drug Manufacturing

Global life sciences leader Cytiva is addressing the distinct filtration needs of customers manufacturing high-concentration biologic drugs with its Supor ...

June 28, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

June 25, 2024 | News

EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer

— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...

June 24, 2024 | News

Merck’s SMCxPRO® Immunoassay Technology Advances Parkinson’s Disease Research Through MJFF Collaboration

SMC® immunoassay technology from Merck detects small changes in biomarker levels, indicating level of cell dysfunction New understanding of cel...

June 24, 2024 | News

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News

Sarepta Therapeutics Secures FDA Approval for Expanded Use of ELEVIDYS in Duchenne Muscular Dystrophy Patients

Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) approv...

June 21, 2024 | News

YolTech Partners with KACTUS to Commercialize Breakthrough DNA Editor YolCas12TM in Greater China

YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery for in vivo gene editing therapies, has partnered with KACT...

June 19, 2024 | News

ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration

ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...

June 18, 2024 | News

Aptamer Group Partners with Microsaic Systems to Develop Advanced Waterborne Pathogen Detection

New binders will be developed to multiple waterborne pathogens Optimer will support continuous water monitoring for rapid detection Aptamer Group the...

June 17, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

June 11, 2024 | News

Alphamab Oncology and ArriVent BioPharma Forge Strategic Collaboration to Develop Novel Antibody Drug Conjugates

Alphamab Oncology announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. , a wholly-owned subsidiary of the Company, entered into a research an...

June 06, 2024 | News

Annogen and Orchard Therapeutics Partner for Innovative Gene Therapy Research

Annogen, a company with expertise in bespoke promoter design and gene expression engineering, announced a research collaboration with Orchard Therape...

June 06, 2024 | News

South Africa to Bolster Pharmaceutical Sovereignty with Cutting-Edge Biotherapeutic Platform

Technology transfer will strengthen South Africa’s pharmaceutical sovereignty and drastically reduce production costs, thus improving affordability a...

June 04, 2024 | News

AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC

Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...

June 03, 2024 | News

Stay Connected